Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders

Alexander J. Gill, Colleen E. Kovacsics, Stephanie A. Cross, Patricia J. Vance, Lorraine L. Kolson, Kelly L. Jordan-Sciutto, Benjamin Gelman, Dennis L. Kolson

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Heme oxygenase-1 (HO-1) is an inducible, detoxifying enzyme that is critical for limiting oxidative stress, inflammation, and cellular injury within the CNS and other tissues. Here, we demonstrate a deficiency of HO-1 expression in the brains of HIV-infected individuals. This HO-1 deficiency correlated with cognitive dysfunction, HIV replication in the CNS, and neuroimmune activation. In vitro analysis of HO-1 expression in HIV-infected macrophages, a primary CNS HIV reservoir along with microglia, demonstrated a decrease in HO-1 as HIV replication increased. HO-1 deficiency correlated with increased culture supernatant glutamate and neurotoxicity, suggesting a link among HIV infection, macrophage HO-1 deficiency, and neurodegeneration. HO-1 siRNA knockdown and HO enzymatic inhibition in HIV-infected macrophages increased supernatant glutamate and neurotoxicity. In contrast, increasing HO-1 expression through siRNA derepression or with nonselective pharmacologic inducers, including the CNS-penetrating drug dimethyl fumarate (DMF), decreased supernatant glutamate and neurotoxicity. Furthermore, IFN-γ, which is increased in CNS HIV infection, reduced HO-1 expression in cultured human astrocytes and macrophages. These findings indicate that HO-1 is a protective host factor against HIV-mediated neurodegeneration and suggest that HO-1 deficiency contributes to this degeneration. Furthermore, these results suggest that HO-1 induction in the CNS of HIV-infected patients on antiretroviral therapy could potentially protect against neurodegeneration and associated cognitive dysfunction.

Original languageEnglish (US)
Pages (from-to)4459-4472
Number of pages14
JournalJournal of Clinical Investigation
Volume124
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Heme Oxygenase-1
HIV
Macrophages
Glutamic Acid
Small Interfering RNA
HIV Infections
Heme Oxygenase 1 Deficiency
Neurocognitive Disorders
Microglia
Astrocytes
Oxidative Stress
Inflammation
Wounds and Injuries
Brain
Enzymes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gill, A. J., Kovacsics, C. E., Cross, S. A., Vance, P. J., Kolson, L. L., Jordan-Sciutto, K. L., ... Kolson, D. L. (2014). Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. Journal of Clinical Investigation, 124(10), 4459-4472. https://doi.org/10.1172/JCI72279

Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. / Gill, Alexander J.; Kovacsics, Colleen E.; Cross, Stephanie A.; Vance, Patricia J.; Kolson, Lorraine L.; Jordan-Sciutto, Kelly L.; Gelman, Benjamin; Kolson, Dennis L.

In: Journal of Clinical Investigation, Vol. 124, No. 10, 01.10.2014, p. 4459-4472.

Research output: Contribution to journalArticle

Gill, AJ, Kovacsics, CE, Cross, SA, Vance, PJ, Kolson, LL, Jordan-Sciutto, KL, Gelman, B & Kolson, DL 2014, 'Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders', Journal of Clinical Investigation, vol. 124, no. 10, pp. 4459-4472. https://doi.org/10.1172/JCI72279
Gill AJ, Kovacsics CE, Cross SA, Vance PJ, Kolson LL, Jordan-Sciutto KL et al. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. Journal of Clinical Investigation. 2014 Oct 1;124(10):4459-4472. https://doi.org/10.1172/JCI72279
Gill, Alexander J. ; Kovacsics, Colleen E. ; Cross, Stephanie A. ; Vance, Patricia J. ; Kolson, Lorraine L. ; Jordan-Sciutto, Kelly L. ; Gelman, Benjamin ; Kolson, Dennis L. / Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. In: Journal of Clinical Investigation. 2014 ; Vol. 124, No. 10. pp. 4459-4472.
@article{c998787d64ae4df097398b1b6869bdf1,
title = "Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders",
abstract = "Heme oxygenase-1 (HO-1) is an inducible, detoxifying enzyme that is critical for limiting oxidative stress, inflammation, and cellular injury within the CNS and other tissues. Here, we demonstrate a deficiency of HO-1 expression in the brains of HIV-infected individuals. This HO-1 deficiency correlated with cognitive dysfunction, HIV replication in the CNS, and neuroimmune activation. In vitro analysis of HO-1 expression in HIV-infected macrophages, a primary CNS HIV reservoir along with microglia, demonstrated a decrease in HO-1 as HIV replication increased. HO-1 deficiency correlated with increased culture supernatant glutamate and neurotoxicity, suggesting a link among HIV infection, macrophage HO-1 deficiency, and neurodegeneration. HO-1 siRNA knockdown and HO enzymatic inhibition in HIV-infected macrophages increased supernatant glutamate and neurotoxicity. In contrast, increasing HO-1 expression through siRNA derepression or with nonselective pharmacologic inducers, including the CNS-penetrating drug dimethyl fumarate (DMF), decreased supernatant glutamate and neurotoxicity. Furthermore, IFN-γ, which is increased in CNS HIV infection, reduced HO-1 expression in cultured human astrocytes and macrophages. These findings indicate that HO-1 is a protective host factor against HIV-mediated neurodegeneration and suggest that HO-1 deficiency contributes to this degeneration. Furthermore, these results suggest that HO-1 induction in the CNS of HIV-infected patients on antiretroviral therapy could potentially protect against neurodegeneration and associated cognitive dysfunction.",
author = "Gill, {Alexander J.} and Kovacsics, {Colleen E.} and Cross, {Stephanie A.} and Vance, {Patricia J.} and Kolson, {Lorraine L.} and Jordan-Sciutto, {Kelly L.} and Benjamin Gelman and Kolson, {Dennis L.}",
year = "2014",
month = "10",
day = "1",
doi = "10.1172/JCI72279",
language = "English (US)",
volume = "124",
pages = "4459--4472",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders

AU - Gill, Alexander J.

AU - Kovacsics, Colleen E.

AU - Cross, Stephanie A.

AU - Vance, Patricia J.

AU - Kolson, Lorraine L.

AU - Jordan-Sciutto, Kelly L.

AU - Gelman, Benjamin

AU - Kolson, Dennis L.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Heme oxygenase-1 (HO-1) is an inducible, detoxifying enzyme that is critical for limiting oxidative stress, inflammation, and cellular injury within the CNS and other tissues. Here, we demonstrate a deficiency of HO-1 expression in the brains of HIV-infected individuals. This HO-1 deficiency correlated with cognitive dysfunction, HIV replication in the CNS, and neuroimmune activation. In vitro analysis of HO-1 expression in HIV-infected macrophages, a primary CNS HIV reservoir along with microglia, demonstrated a decrease in HO-1 as HIV replication increased. HO-1 deficiency correlated with increased culture supernatant glutamate and neurotoxicity, suggesting a link among HIV infection, macrophage HO-1 deficiency, and neurodegeneration. HO-1 siRNA knockdown and HO enzymatic inhibition in HIV-infected macrophages increased supernatant glutamate and neurotoxicity. In contrast, increasing HO-1 expression through siRNA derepression or with nonselective pharmacologic inducers, including the CNS-penetrating drug dimethyl fumarate (DMF), decreased supernatant glutamate and neurotoxicity. Furthermore, IFN-γ, which is increased in CNS HIV infection, reduced HO-1 expression in cultured human astrocytes and macrophages. These findings indicate that HO-1 is a protective host factor against HIV-mediated neurodegeneration and suggest that HO-1 deficiency contributes to this degeneration. Furthermore, these results suggest that HO-1 induction in the CNS of HIV-infected patients on antiretroviral therapy could potentially protect against neurodegeneration and associated cognitive dysfunction.

AB - Heme oxygenase-1 (HO-1) is an inducible, detoxifying enzyme that is critical for limiting oxidative stress, inflammation, and cellular injury within the CNS and other tissues. Here, we demonstrate a deficiency of HO-1 expression in the brains of HIV-infected individuals. This HO-1 deficiency correlated with cognitive dysfunction, HIV replication in the CNS, and neuroimmune activation. In vitro analysis of HO-1 expression in HIV-infected macrophages, a primary CNS HIV reservoir along with microglia, demonstrated a decrease in HO-1 as HIV replication increased. HO-1 deficiency correlated with increased culture supernatant glutamate and neurotoxicity, suggesting a link among HIV infection, macrophage HO-1 deficiency, and neurodegeneration. HO-1 siRNA knockdown and HO enzymatic inhibition in HIV-infected macrophages increased supernatant glutamate and neurotoxicity. In contrast, increasing HO-1 expression through siRNA derepression or with nonselective pharmacologic inducers, including the CNS-penetrating drug dimethyl fumarate (DMF), decreased supernatant glutamate and neurotoxicity. Furthermore, IFN-γ, which is increased in CNS HIV infection, reduced HO-1 expression in cultured human astrocytes and macrophages. These findings indicate that HO-1 is a protective host factor against HIV-mediated neurodegeneration and suggest that HO-1 deficiency contributes to this degeneration. Furthermore, these results suggest that HO-1 induction in the CNS of HIV-infected patients on antiretroviral therapy could potentially protect against neurodegeneration and associated cognitive dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=84907486040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907486040&partnerID=8YFLogxK

U2 - 10.1172/JCI72279

DO - 10.1172/JCI72279

M3 - Article

C2 - 25202977

AN - SCOPUS:84907486040

VL - 124

SP - 4459

EP - 4472

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -